Dermatologists reviewing cutaneous manifestations can uncover hidden gastrointestinal disorders by evaluating painful skin ulcerations and inflammatory nodules associated with Crohn disease and ulcerative colitis, Dermatology Times reported.
Unexplained skin findings frequently serve as the first visible indicator of internal systemic pathology before organ-specific symptoms become fully apparent. While patients often present seeking localized dermatologic treatment, underlying inflammatory bowel diseases require distinct medical management that addresses both cutaneous manifestations and internal gastrointestinal pathways.
Skin Conditions Signal Hidden Digestive Diseases
- Systemic Link: Skin conditions like painful ulcers or tender nodules can point directly to hidden digestive tract diseases such as Crohn disease or ulcerative colitis.
- Targeted Screening: Dermatologists are encouraged to ask about bowel habits, abdominal cramps, and bloody diarrhea when examining unusual inflammatory skin lesions.
- Medication Caution: Certain skin treatments, particularly interleukin-17 inhibitors, require careful gastrointestinal evaluation because they can potentially worsen underlying bowel inflammation.
Recognizing Gastrointestinal Clues Through Skin Evaluation
Oral ulcers, weight loss, and other systemic symptoms may provide additional clues.
Pyoderma gangrenosum was highlighted as an important consideration in patients presenting with rapidly progressive, painful ulcerations. Faculty emphasized pathergy, a phenomenon in which minor trauma can trigger or worsen inflammatory lesions.

The discussion also addressed the characteristic appearance of some lesions, including undermined borders and surrounding violaceous discoloration.
Erythema Nodosum and Cutaneous Granulomatous Lesions Linked to Systemic Disease
Erythema nodosum was discussed as another inflammatory condition that may indicate underlying systemic disease.
Clinical manifestations may include inflammatory plaques, nodules, fissures, and ulcerations involving genital, perianal, or other cutaneous sites. Biopsy findings may demonstrate noncaseating granulomas, although other infectious and inflammatory causes must be considered.
Beyond gastrointestinal disorders, the session highlighted the importance of recognizing dermatologic manifestations of systemic autoimmune disease.
Systemic Autoimmune Signs and Nailfold Assessments
Faculty reviewed characteristic manifestations of dermatomyositis, including violaceous periorbital discoloration, shawl-sign erythema, cuticular abnormalities, and nailfold changes.
Meanwhile, medscape.com reported that a first impression of a patient’s skin can help guide the differential diagnosis and provide clues to underlying diseases associated with cutaneous changes. Some findings may serve as early warning signs before organ-specific manifestations develop, including paleness indicating anemia or renal insufficiency, and cyanosis resulting from heart disease.
| Dermatologic Finding | Potential Systemic Association | Key Clinical Clue |
|---|---|---|
| Pyoderma gangrenosum | Inflammatory bowel disease, rheumatologic or hematologic disorders | Rapidly progressive, painful ulcerations with undermined borders and pathergy |
| Erythema nodosum | Crohn disease, ulcerative colitis, streptococcal infections | Tender subcutaneous nodules typically appearing on the lower legs |
| Dermatitis herpetiformis | Celiac disease (gluten-sensitive enteropathy) | Severe, burning pruritus with recurrent crops of papules and vesicles |
| Sister Mary Joseph nodule | Gastrointestinal or gynecologic malignancies | Metastatic nodule located around the umbilicus |
Treatment Selection and Gastrointestinal Comorbidities
The session also addressed the implications of underlying gastrointestinal disease when selecting systemic dermatologic therapies. Faculty discussed the relationship between cytokine inhibition and intestinal inflammation, particularly among patients with psoriasis and coexisting inflammatory bowel disease. Interleukin-17 inhibitors were identified as treatments requiring particular consideration in patients with inflammatory bowel disease because of concerns about exacerbating intestinal inflammation.
In contrast, interleukin-23–targeted therapies were discussed as options with evidence supporting efficacy in both psoriasis and certain forms of inflammatory bowel disease. Janus kinase inhibitors were also discussed, including considerations related to acne and elevated liver enzyme levels.
Faculty highlighted the importance of appropriate laboratory monitoring and patient counseling when initiating systemic therapies.
Patients with Bowel Disease Should Avoid Self-Treating Skin Lesions
Patients with known inflammatory bowel disease or unexplained recurrent skin ulcerations, tender subcutaneous nodules, or treatment-resistant rashes should avoid self-treating with systemic dermatologic agents before a comprehensive medical evaluation. Specifically, interleukin-17 inhibitors are contraindicated or require extreme caution in patients with active gastrointestinal inflammation due to the risk of exacerbating bowel disease.
Medical intervention and specialist referral to gastroenterology or dermatology are warranted immediately if patients experience persistent abdominal cramping, unexplained weight loss, bloody diarrhea, nocturnal bowel movements, or rapidly progressive painful skin lesions with violaceous borders.
References
- Guttman-Yassky E, Croft M, Geng B, et al. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis. Br J Dermatol. 2024;191(4):488-496. doi:10.1093/bjd/ljae230.
- Metz M, Giménez-Arnau A, Hide M, et al. Remibrutinib in chronic spontaneous urticaria. N Engl J Med. 2025;392(10):984-994. doi:10.1056/NEJMoa2408792.
- Ingram JR, et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol. 2019;180(5):1009-1017. doi:10.1111/bjd.17537.
- Dermatitis herpetiformis management and celiac disease association. PubMed.
- Bazex syndrome and systemic malignancy correlations. PubMed.
Keep reading
- Dr. Dossett and Experts: Breathing, Writing, Nature, Apps Cut Stress Fast
- Human Concept Neurons Reactivate During Sleep to Reflect Content, Not Event Sequence
- Police and Experts Urge Parents to Spot Online Stalking Signs as Cases Rise (newsy-today.com)
- Trump Signs Common Cents Act, Ending Penny Production Permanently (archyworldys.com)